Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR) Novartis (Press Release) 16:15 Fri, 18 Sep
BoomRay and Novartis Pharma sign $900m deal for radioligand therapy Pharmaceutical Business Review 10:45 Wed, 23 Sep BoomRay Pharma Biotechnology
Samsung Bioepis, Teva enter commercialization agreement on 6 biosimilar candidates The Korea Times 1d Consumer Electronics AstraZeneca Teva
Novartis’ Cosentyx gets positive CHMP opinion for polymyalgia rheumatica PMLiVE 13:14 Mon, 21 Sep Cosentyx Pharma CHMP
Novartis halts experimental ALS drug trial but acquires brain delivery platform Benzinga 17:49 Thu, 17 Sep VHB937 Article paywall
